UroGen Pharma (URGN) FCF Margin Growth (3y) (2020 - 2026)
UroGen Pharma (URGN) FCF Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | UroGen Pharma | 2.13 Bn | 1.99 Bn | 46.82 Mn | 5,906.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,906.00 |
| Dec 31, 2025 | 2,465.00 |
| Sep 30, 2025 | -6,262.00 |
| Jun 30, 2025 | -1,884.00 |
| Mar 31, 2025 | -2,825.00 |
| Dec 31, 2024 | 6,434.00 |
| Sep 30, 2024 | 5,903.00 |
| Jun 30, 2024 | 4,429.00 |
| Mar 31, 2024 | 20,594.00 |
| Dec 31, 2023 | 21,364.00 |
| Sep 30, 2023 | 66,443.00 |
| Jun 30, 2023 | 641,540.00 |
| Jun 30, 2022 | 8.09 Mn |
| Sep 30, 2021 | 322,852.00 |
| Jun 30, 2021 | 212,341.00 |
| Mar 31, 2021 | 164,589.00 |
| Dec 31, 2020 | 160,030.00 |
| Sep 30, 2020 | -77,670.00 |